‘Substantial Demand’ for Abortion Pills Ordered in Advance, Study Finds
TUESDAY, Jan. 2, 2024 (HealthDay News) — A U.S. online provider of the mifepristone/misoprostol abortion pill combo saw a ten-fold jump in orders when the Dobbs decision overturning Roe v. Wade was first leaked in 2022, a new study finds. Such orders declined a bit in the months after theContinue Reading